127 related articles for article (PubMed ID: 30698823)
1. Impact of treating facilities' type and volume in patients with major salivary gland cancer.
Bollig CA; Zitsch RP
Laryngoscope; 2019 Oct; 129(10):2321-2327. PubMed ID: 30698823
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
[TBL] [Abstract][Full Text] [Related]
3. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
4. Facility Volume and Survival in Nasopharyngeal Carcinoma.
Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Lee NY; Ho AS; Zumsteg ZS
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):408-417. PubMed ID: 29100787
[TBL] [Abstract][Full Text] [Related]
5. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
[TBL] [Abstract][Full Text] [Related]
6. Trimodality therapy for esophageal cancer at high volume facilities is associated with improved postoperative outcomes and overall survival.
Haque W; Verma V; Butler EB; Teh BS
Dis Esophagus; 2019 Apr; 32(4):. PubMed ID: 30052835
[TBL] [Abstract][Full Text] [Related]
7. Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic Carcinomas.
Cassidy RJ; Switchenko JM; El-Deiry MW; Belcher RH; Zhong J; Steuer CE; Saba NF; McDonald MW; Yu DS; Gillespie TW; Beitler JJ
Laryngoscope; 2019 Feb; 129(2):377-386. PubMed ID: 30194768
[TBL] [Abstract][Full Text] [Related]
8. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.
Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD
JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166
[TBL] [Abstract][Full Text] [Related]
9. Association Between Treatment at High-Volume Facilities and Improved Overall Survival in Soft Tissue Sarcomas.
Venigalla S; Nead KT; Sebro R; Guttmann DM; Sharma S; Simone CB; Levin WP; Wilson RJ; Weber KL; Shabason JE
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1004-1015. PubMed ID: 29485042
[TBL] [Abstract][Full Text] [Related]
10. Facility Volume as a Prognosticator of Survival in Locally Advanced Papillary Thyroid Cancer.
Abiri A; Pang JC; Roman K; Goshtasbi K; Birkenbeuel JL; Kuan EC; Tjoa T; Haidar YM
Laryngoscope; 2023 Feb; 133(2):443-450. PubMed ID: 35822421
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma.
Cheraghlou S; Schettino A; Zogg CK; Otremba MD; Bhatia A; Park HS; Osborn HA; Mehra S; Yarbrough WG; Judson BL
Laryngoscope; 2019 Apr; 129(4):883-889. PubMed ID: 30151947
[TBL] [Abstract][Full Text] [Related]
12. Patterns of care and survival of adjuvant radiation for major salivary adenoid cystic carcinoma.
Lee A; Givi B; Osborn VW; Schwartz D; Schreiber D
Laryngoscope; 2017 Sep; 127(9):2057-2062. PubMed ID: 28194862
[TBL] [Abstract][Full Text] [Related]
13. Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.
Chen YW; Mahal BA; Muralidhar V; Nezolosky M; Beard CJ; Den RB; Feng FY; Hoffman KE; Martin NE; Orio PF; Nguyen PL
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):683-90. PubMed ID: 26972640
[TBL] [Abstract][Full Text] [Related]
14. Association between facility volume and mortality of patients with classic Hodgkin lymphoma.
Goyal G; Tella SH; Funni S; Kommalapati A; Inselman JW; Shah ND; Go RS; Ansell SM
Cancer; 2020 Feb; 126(4):757-764. PubMed ID: 31714588
[TBL] [Abstract][Full Text] [Related]
15. Basal cell adenocarcinoma of the major salivary glands: A population-level study of 509 cases.
Zhan KY; Lentsch EJ
Laryngoscope; 2016 May; 126(5):1086-90. PubMed ID: 26451535
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database.
Cheraghlou S; Kuo P; Mehra S; Agogo GO; Bhatia A; Husain ZA; Yarbrough WG; Burtness BA; Judson BL
Head Neck; 2018 Jul; 40(7):1343-1355. PubMed ID: 29756412
[TBL] [Abstract][Full Text] [Related]
17. Survival Impact of Adjuvant Therapy in Salivary Gland Cancers following Resection and Neck Dissection.
Aro K; Ho AS; Luu M; Kim S; Tighiouart M; Yoshida EJ; Mallen-St Clair J; Shiao SL; Leivo I; Zumsteg ZS
Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1048-1057. PubMed ID: 30721113
[TBL] [Abstract][Full Text] [Related]
18. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
Zhu P; Du XL; Zhu JJ; Esquenazi Y
J Neurosurg; 2019 Feb; 132(2):491-502. PubMed ID: 30771780
[TBL] [Abstract][Full Text] [Related]
19. Closing the gap: Contribution of surgical best practices to outcome differences between high- and low-volume centers for lung cancer resection.
von Itzstein MS; Lu R; Kernstine KH; Halm EA; Wang S; Xie Y; Gerber DE
Cancer Med; 2020 Jun; 9(12):4137-4147. PubMed ID: 32319225
[TBL] [Abstract][Full Text] [Related]
20. Impact of facility type and volume in low-grade glioma outcomes.
Zhu P; Du XL; Blanco AI; Ballester LY; Tandon N; Berger MS; Zhu JJ; Esquenazi Y
J Neurosurg; 2019 Sep; 133(5):1313-1323. PubMed ID: 31561219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
